Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045892
Filing Date
2024-11-14
Accepted
2024-11-14 16:15:39
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 974830
2 ex31-1.htm EX-31.1 21453
3 ex31-2.htm EX-31.2 20903
4 ex32-1.htm EX-32.1 7113
5 ex32-2.htm EX-32.2 6571
6 form10-q_001.jpg GRAPHIC 304589
7 form10-q_002.jpg GRAPHIC 67927
8 form10-q_003.jpg GRAPHIC 15073
9 form10-q_004.jpg GRAPHIC 86898
10 form10-q_005.jpg GRAPHIC 15203
11 form10-q_006.jpg GRAPHIC 12417
  Complete submission text file 0001493152-24-045892.txt   6444502

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE gtbp-20240930.xsd EX-101.SCH 40424
13 XBRL CALCULATION FILE gtbp-20240930_cal.xml EX-101.CAL 35177
14 XBRL DEFINITION FILE gtbp-20240930_def.xml EX-101.DEF 175323
15 XBRL LABEL FILE gtbp-20240930_lab.xml EX-101.LAB 328159
16 XBRL PRESENTATION FILE gtbp-20240930_pre.xml EX-101.PRE 257870
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 866903
Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 241462531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)